These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 9811464
1. Is conversion of solid into more anoxic ascites tumors associated with p53 inactivation? Magnusson KP, Satalino R, Qian W, Klein G, Wiman KG. Oncogene; 1998 Nov 05; 17(18):2333-7. PubMed ID: 9811464 [Abstract] [Full Text] [Related]
2. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development. Jerry DJ, Ozbun MA, Kittrell FS, Lane DP, Medina D, Butel JS. Cancer Res; 1993 Jul 15; 53(14):3374-81. PubMed ID: 8324748 [Abstract] [Full Text] [Related]
3. p53 mutations selected in vivo when mouse mammary epithelial cells form hyperplastic outgrowths are not necessary for establishment of mammary cell lines in vitro. Ozbun MA, Jerry DJ, Kittrell FS, Medina D, Butel JS. Cancer Res; 1993 Apr 01; 53(7):1646-52. PubMed ID: 8453637 [Abstract] [Full Text] [Related]
4. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene. Murakami T, Tokunaga N, Waku T, Gomi S, Kagawa S, Tanaka N, Fujiwara T. Clin Cancer Res; 2004 Jun 01; 10(11):3871-80. PubMed ID: 15173096 [Abstract] [Full Text] [Related]
5. Adenovirus-mediated p53 gene therapy inhibits human sarcoma tumorigenicity. Milas M, Yu D, Lang A, Ge T, Feig B, El-Naggar AK, Pollock RE. Cancer Gene Ther; 2000 Mar 01; 7(3):422-9. PubMed ID: 10766348 [Abstract] [Full Text] [Related]
6. p53 protects against skin cancer induction by UV-B radiation. Jiang W, Ananthaswamy HN, Muller HK, Kripke ML. Oncogene; 1999 Jul 22; 18(29):4247-53. PubMed ID: 10435637 [Abstract] [Full Text] [Related]
7. Canarypox virus expressing wild type p53 for gene therapy in murine tumors mutated in p53. Odin L, Favrot M, Poujol D, Michot JP, Moingeon P, Tartaglia J, Puisieux I. Cancer Gene Ther; 2001 Feb 22; 8(2):87-98. PubMed ID: 11263530 [Abstract] [Full Text] [Related]
8. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice. Wang Y, Zhang Z, Kastens E, Lubet RA, You M. Cancer Res; 2003 Aug 01; 63(15):4389-95. PubMed ID: 12907609 [Abstract] [Full Text] [Related]
9. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus. Zelazny E, Li B, Anagnostopoulos AM, Coleman A, Perkins AS. Exp Mol Pathol; 2001 Jun 01; 70(3):183-93. PubMed ID: 11417997 [Abstract] [Full Text] [Related]
10. p53 transdominance but no gain of function in mouse brain tumor model. Hegi ME, Klein MA, Rüedi D, Chène P, Hamou MF, Aguzzi A. Cancer Res; 2000 Jun 01; 60(11):3019-24. PubMed ID: 10850451 [Abstract] [Full Text] [Related]
11. Effect of p53 status on tumor response to antiangiogenic therapy. Yu JL, Rak JW, Coomber BL, Hicklin DJ, Kerbel RS. Science; 2002 Feb 22; 295(5559):1526-8. PubMed ID: 11859195 [Abstract] [Full Text] [Related]
12. Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters. Baumbusch LO, Myhre S, Langerød A, Bergamaschi A, Geisler SB, Lønning PE, Deppert W, Dornreiter I, Børresen-Dale AL. Mol Cancer; 2006 Oct 20; 5():47. PubMed ID: 17054774 [Abstract] [Full Text] [Related]
13. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells. Masunaga S, Uto Y, Nagasawa H, Hori H, Nagata K, Suzuki M, Kinashi Y, Ono K. Anticancer Res; 2006 Oct 20; 26(2A):1261-70. PubMed ID: 16619533 [Abstract] [Full Text] [Related]
14. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors. Tam AS, Foley JF, Devereux TR, Maronpot RR, Massey TE. Cancer Res; 1999 Aug 01; 59(15):3634-40. PubMed ID: 10446974 [Abstract] [Full Text] [Related]
15. Effects of mild temperature hyperthermia and p53 status on the size of hypoxic fractions in solid tumors, with reference to the effect in intratumor quiescent cell populations. Masunaga S, Takahashi A, Ohnishi K, Ohnishi T, Nagata K, Suzuki M, Kinashi Y, Ono K. Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):570-7. PubMed ID: 15380594 [Abstract] [Full Text] [Related]
16. A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer. Oakley R, Phillips E, Hooper R, Wilson D, Partridge M. Clin Cancer Res; 2002 Jun 01; 8(6):1984-94. PubMed ID: 12060644 [Abstract] [Full Text] [Related]
17. Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53. St John LS, Sauter ER, Herlyn M, Litwin S, Adler-Storthz K. Cancer Gene Ther; 2000 May 01; 7(5):749-56. PubMed ID: 10830722 [Abstract] [Full Text] [Related]
18. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis. Andrews GA, Xi S, Pomerantz RG, Lin CJ, Gooding WE, Wentzel AL, Wu L, Sidransky D, Grandis JR. Head Neck; 2004 Oct 01; 26(10):870-7. PubMed ID: 15390206 [Abstract] [Full Text] [Related]
19. Increased oncogenicity of subclones of SV40 large T-induced neuroectodermal tumor cell lines after loss of large T expression and concomitant mutation in p53. Salewski H, Bayer TA, Eidhoff U, Preuss U, Weggen S, Scheidtmann KH. Cancer Res; 1999 Apr 15; 59(8):1980-6. PubMed ID: 10213510 [Abstract] [Full Text] [Related]
20. Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein. Wesierska-Gadek J, Schmid G. Cell Mol Biol Lett; 2001 Apr 15; 6(2):117-40. PubMed ID: 11544635 [Abstract] [Full Text] [Related] Page: [Next] [New Search]